{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-231963","form_type":"8-K","ticker":"CORT","cik":"0001088856","company_name":"CORCEPT THERAPEUTICS INC","filed_at":"2025-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.765013+00:00","generated_at":"2026-05-17T04:32:36.218200+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Gillian Cannon resigns from Corcept board; consulting agreement signed","bullets":["Dr. Gillian Cannon resigned from the Board effective October 10, 2025, with no disagreement over operations or policies.","Company and Cannon entered consulting agreement from effective date until 2026 annual stockholder meeting.","Consulting fee: $5,708.33 per month; previously awarded stock options continue vesting per original schedule."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-231963","json":"https://secwatch.observer/filing/0001193125-25-231963.json","markdown":"https://secwatch.observer/filing/0001193125-25-231963.md","text":"https://secwatch.observer/filing/0001193125-25-231963.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525231963/0001193125-25-231963-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525231963/d817312d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:32:36.218200+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}